NexImmune Inc (NAS:NEXI)
$ 2.37 -0.11 (-4.44%) Market Cap: 3.25 Mil Enterprise Value: -1.33 Mil PE Ratio: 0 PB Ratio: 1.10 GF Score: 36/100

Neximmune Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 12, 2022 / 03:00PM GMT
Release Date Price: $23.07 (-8.65%)
Matt Keller
H.C. Wainwright & Co., LLC - Analyst

Good morning, everyone, and welcome to the H.C. Wainwright 24th Annual Global Investment Conference. My name is Matt Keller. I'm an associate in the equity research department.

With that said, I want to introduce our next presenter, Kristi Jones, the CEO of Neximmune. With that, Kristi, please take it away.

Kristi Jones
Neximmune, Inc. - CEO

Fantastic. Thank you so much for this invitation to speak at the conference. So great to be here in person and see friendly faces that we haven't been able to see in person for so long. And I think everybody's probably starting with something very similar to that.

So let me just start giving maybe a brief context of Neximmune. Our platform technology is called AIM, the Artificial Immune Modulating platform. Our vision is to drive cell-mediated immune responses that have potential for cure in various diseases specific -- that have engine-specific components.

Let me just kind of walk through a little bit about how that mechanism fits and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot